Benefits of minimal residual disease negativity in the therapy of chronic lymphocytic leukemia.

Research output: Contribution to journalArticle

Original languageEnglish (US)
Pages (from-to)727-729
Number of pages3
JournalClinical advances in hematology & oncology : H&O
Volume6
Issue number10
StatePublished - Oct 2008

ASJC Scopus subject areas

  • Hematology
  • Oncology

Cite this